The appointments, which deepen Envision’s senior management team led by Chief Executive Officer Jim Rechtin, follow the addition of Chan Chuang, MD, FCCP, FACP, as the medical group’s first national Chief Medical Officer earlier this year. Booysen, Moore and Dr. Chuang will all report directly to Rechtin.
“We are thrilled to welcome Wes and Ilene to the team,” said Rechtin. “Wes is a proven leader and financial expert who has contributed to the transformative growth of global organizations. He will be an important part of a senior leadership team focused on supporting our doctors and advanced practice providers so they can do the job that matters most – caring for patients.”
Booysen CPA, CA, previously served as Managing Director and CEO for Molson Coors Beverage Company for Asia Pacific and Africa. Before that, he spent five years as CFO of Molson Coors International where he built a globally based finance team responsible for overseeing Accounting, Financial Planning and Analysis, Investor Relations, SEC Reporting, Internal Controls, Mergers and Acquisitions and growth strategy across more than 70 countries. He succeeds Teresa Sparks, who will remain an advisor to Envision, ensuring a smooth transition of responsibilities.
“We are grateful to Teresa for her many contributions during the past couple of years as we began our journey as a private group and, most notably, in helping to navigate the challenges of COVID-19,” said Rechtin.
As General Counsel, Moore will bring highly relevant experience to Envision, having served as a trusted legal advisor for the betterment of healthcare and public policy for more than two decades. She most recently held the position of Senior Vice President and General Counsel at the Health Information and Management Systems Society. She was previously General Counsel for DaVita Medical Group and before that with the Medical Groups of Kaiser Permanente. Moore will succeed Craig Wilson who is transitioning from the General Counsel role after 20 years with Envision.
“Ilene’s dedication to high-quality patient care is well-aligned with our mission as a national medical group, and I am confident that her expertise will be invaluable to Envision going forward,” added Rechtin. “We are grateful to Craig for his stewardship of Envision’s legal affairs during the years and we wish him well as he seeks his next challenge.”
Envision has taken a leading position in responding to America’s call for COVID-19 care. Learn more about the national medical group’s actions to support clinicians, healthcare partners and patients by visiting: www.envisionhealth.com/coronavirus.
About Envision Healthcare Corporation
Envision Healthcare Corporation is a leading national medical group that delivers physician and advanced practice provider services, primarily in the areas of emergency and hospitalist medicine, anesthesiology, radiology/teleradiology, and neonatology to more than 1,800 clinical departments in healthcare facilities in 45 states and the District of Columbia. Post-acute care is delivered through an array of clinical professionals and integrated technologies which, when combined, contribute to efficient and effective population health management strategies. As a market leader in ambulatory surgical care, the medical group owns and operates 257 surgery centers and one surgical hospital in 34 states and the District of Columbia, with medical specialties ranging from gastroenterology to ophthalmology and orthopedics. In total, the medical group offers a differentiated suite of clinical solutions on a national scale with a local understanding of our communities, creating value for health systems, payers, providers, and patients. For additional information, visit www.envisionhealth.com.